Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Check out some of our latest original content that was created and distributed as part of our ongoing collaborations with IR firms and other companies.

MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Applies for FDA Commissioner’s Priority Voucher for NRX-100 Ketamine Formulation

Posted on June 23, 2025 by MissionIR

NRx Pharmaceuticals (NASDAQ: NRXP) has filed for the newly launched FDA Commissioner’s National Priority Voucher (CNPV) program, seeking accelerated review for NRX-100, its preservative-free intravenous ketamine formulation. The company believes NRX-100 meets all criteria outlined by FDA Commissioner Marty Makary, who announced the voucher program on June 17, 2025, to prioritize treatments aligned with urgent U.S. health needs—including suicidal depression and PTSD.

NRx has already submitted the chemistry, manufacturing, and controls (CMC) portion of its application and received FDA feedback, placing it on track for potential accelerated review of its full New Drug Application (NDA) by late 2025. If granted, the voucher would cut review times to 1–2 months versus the standard 10–12 months. Concurrently, NRx is advancing a citizen petition to withdraw preservative-containing ketamine products and has filed a patent for its preservative-free manufacturing process, aiming to capture share in a ketamine market projected to reach up to $5 billion annually by 2033.To view the full press release, visit https://ibn.fm/YNhvT

About NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRx plans to file an NDA for Accelerated Approval for NRX-101 in patients with bipolar depression and suicidality or akathisia. NRX-101 additionally has potential to act as a non-opioid treatment for chronic pain, as well as a treatment for complicated UTI.

NRx has recently initiated a New Drug Application filing for NRX-100 (IV ketamine) for the treatment of suicidal depression, based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and newly obtained data from French health authorities, licensed under a data sharing agreement. NRx was awarded Fast Track Designation for development of ketamine (NRX-100) by the US FDA as part of a protocol to treat patients with acute suicidality.

NOTE TO INVESTORS: The latest news and updates relating to NRXP are available in the company’s newsroom at https://ibn.fm/NRXP

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in NRx Pharmaceuticals Inc. NRXP | Leave a comment

MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Price Target Raised to $15 Following AVERSA Fentanyl Manufacturing Milestone

Posted on June 23, 2025 by MissionIR

Nutriband (NASDAQ: NTRB) has received a new $15 price target in an updated report from Robert LeBoyer, Senior Vice President and Equity Research Analyst, Biotechnology, at Noble Capital Markets, following the successful completion of commercial manufacturing and scale-up for AVERSA Fentanyl, its abuse-deterrent transdermal patch developed in partnership with Kindeva.

The report highlights this milestone as a key inflection point that enables Nutriband to initiate production of clinical supplies and proceed with its planned Investigational New Drug (“IND”) application for a Phase 1 trial. The AVERSA program follows the 505(b)(2) regulatory pathway and requires only a single Phase 1 study, aimed at showing reduced appeal to recreational drug users—a step the analyst views as low risk.

LeBoyer raised his FY2027 EPS forecast to $1.57, citing Nutriband’s adherence to timeline projections and avoidance of a previously expected Q1 2025 equity raise. Full-year sales are projected to begin in FY2027, with the NDA submission expected between late 2025 and early 2026.

To view the full report, visit https://ibn.fm/IWkz5

About Nutriband Inc.

Nutriband is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Its lead product under development is an abuse-deterrent fentanyl patch incorporating its AVERSA(TM) abuse-deterrent technology. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential. For more information about the company, visit www.Nutriband.com.

NOTE TO INVESTORS: The latest news and updates relating to NTRB are available in the company’s newsroom at https://ibn.fm/NTRB

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Nutriband Inc. NTRB | Leave a comment

MissionIRNewsBreaks – Why Silvercorp Metals Inc. (NYSE American: SVM) (TSX: SVM) Is ‘One to Watch’

Posted on June 20, 2025 by MissionIR

Silvercorp Metals (NYSE American: SVM) (TSX: SVM) is a Canadian mining company with a strong track record of profitability, managing a broad portfolio of producing mines, development-stage projects, and exploration assets across China, Ecuador, and Bolivia. The company is committed to maximizing output from its existing operations while strategically advancing new projects to support long-term growth. As noted in a recent article, Silvercorp’s diversified asset base provides both steady cash-flow from current operations and exposure to high-potential projects, positioning the company to deliver lasting value for shareholders.

To view the full article, visit https://ibn.fm/yiUfw

About Silvercorp Metals Inc.

Silvercorp is a Canadian mining company producing silver, gold, lead, and zinc with a long history of profitability and growth potential. The company’s strategy is to create shareholder value by 1) focusing on generating free cash flow from long life mines; 2) organic growth through extensive drilling for discovery; 3) ongoing merger and acquisition efforts to unlock value; and 4) long term commitment to responsible mining and ESG. For more information, visit the company’s website at www.SilverCorpMetals.com.

NOTE TO INVESTORS: The latest news and updates relating to SVM are available in the company’s newsroom at https://ibn.fm/SVM

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Silvercorp Metals Inc. SVM | Leave a comment

Nutriband Inc. (NASDAQ: NTRB) Reimagining Drug Safety Through Scalable Innovation

Posted on June 20, 2025 by MissionIR
  • Nutriband Inc. has been granted a new U.S. patent for its AVERSA(TM) transdermal abuse-deterrent technology, expanding its domestic IP coverage
  • AVERSA(TM) is designed to prevent misuse, abuse, and accidental exposure of transdermal drugs with abuse potential, such as fentanyl
  • With overdose deaths still plaguing the U.S., Nutriband’s platform has the potential to enhance drug safety across multiple therapeutic categories

The opioid crisis remains one of the most persistent public health emergencies in the U.S. While state and federal initiatives have helped curb some of the worst-case trajectories, more than 100,000 Americans still die each year from drug overdoses, a significant proportion linked to synthetic opioids like fentanyl. The crisis is evolving, not disappearing, and the pharmaceutical industry continues to grapple with the challenge of balancing patient access with the need for safety and deterrence.

A key piece of the solution may lie not just in prescribing practices, but in the very design of the drug delivery systems themselves. That’s where companies like Nutriband (NASDAQ: NTRB) are stepping in with novel technologies that aim to prevent abuse at the product level. Recent developments, including a new patent granted by the U.S. Patent and Trademark Office, show the company is doubling down on intellectual property protection as it pushes toward commercialization of its flagship solution.

Understanding the Role of Fentanyl Patches

Fentanyl patches are commonly prescribed for chronic, severe pain in opioid-tolerant patients, such as those with cancer or advanced neurological conditions. They deliver medication steadily over 72 hours, offering consistent relief and better adherence for long-term pain management.

Because fentanyl is 50–100 times stronger than morphine, the patches are not used for short-term or acute pain and carry serious risks, including respiratory depression and overdose, especially in opioid-naïve individuals.

Due to their potency, fentanyl patches are often misused through extraction and abuse, prompting regulatory scrutiny and the need for safer design. Nutriband’s Aversa technology addresses this by incorporating deterrents directly into the patch, helping prevent misuse while preserving therapeutic value. The Aversa platform incorporates extremely sour and incredibly spicy aversive agents into standard drug patches, to prevent tampering, misuse, and accidental exposure, without sacrificing therapeutic benefits for patients who genuinely need these medications.

A New Layer of Protection for Transdermal Drug Delivery

On June 3, 2025, the USPTO granted Patent No. 12,318,492 titled “Abuse and Misuse Deterrent Transdermal Systems”, expanding Nutriband’s domestic IP footprint. This complements an already robust global patent portfolio, with coverage across 46 countries including key pharmaceutical markets in Europe, Japan, China, and Australia.

This isn’t just a legal win; it’s a strategic one. The patent strengthens Nutriband’s ability to protect its competitive edge in a space where innovation can be quickly replicated without proper safeguards. It also enhances the potential value of licensing opportunities with major pharmaceutical firms who could integrate Aversa into their own transdermal offerings.

A Leading Candidate in Abuse-Deterrent Pain Management

At the forefront of Nutriband’s development pipeline is AVERSA(TM) Fentanyl, a transdermal pain patch infused with its abuse-deterrent technology. Fentanyl, despite its clinical importance in treating severe pain, is notoriously prone to abuse and diversion. Patches can be extracted, chewed, or otherwise manipulated to release dangerously high doses.

AVERSA(TM) Fentanyl aims to counter these risks, positioning itself as a first-in-class solution with real potential for impact. According to analysis from Health Advances, peak U.S. sales could range between $80 million and $200 million annually, should the product reach market approval and adoption.

In an industry where safety and efficacy often pull in opposite directions, Nutriband believes it has found a middle ground. Its technology ensures that the therapeutic integrity of transdermal drugs is maintained, while minimizing the potential for dangerous misuse.

An Expanding Opportunity Amid a Persistent Crisis

The importance of solutions like Nutriband’s is amplified by the ongoing realities of the opioid crisis. While recent reports, such as a Virginia Governor’s press release highlighting falling overdose rates in specific counties, suggest progress, the nationwide picture remains troubling. Synthetic opioids continue to outpace other drug categories in overdose fatalities, and the rise of counterfeit medications only worsens the landscape.

The U.S. Food and Drug Administration has long sought innovation in this space, even launching a dedicated Innovation Challenge to spur development of devices and formulations that can prevent or treat opioid use disorder. Nutriband’s platform aligns directly with that mission, providing a product-based safeguard rather than relying solely on behavioral or systemic interventions.

What makes Aversa especially promising is its scalability. Though its initial focus is on fentanyl, the technology could theoretically be applied to any transdermal product susceptible to abuse, opening doors to future formulations in other high-risk categories.

Intellectual Property as a Growth Catalyst

In the pharmaceutical world, IP protection is more than just legal paperwork; it’s a growth engine. NTRB’s ongoing expansion of its patent estate reflects a commitment not just to innovation, but to long-term commercial viability. With patents now secured in 46 countries, the company is laying the groundwork for potential partnerships, licensing agreements, and product rollouts in multiple geographies.

This strategy offers more than just downside protection. It positions Nutriband to benefit from global tailwinds in drug safety regulation. As governments worldwide tighten oversight of high-risk medications, technologies like Aversa that preemptively reduce risk may gain regulatory and market preference.

For more information, visit the company’s website at www.Nutriband.com.

NOTE TO INVESTORS: The latest news and updates relating to NTRB are available in the company’s newsroom at https://ibn.fm/NTRB

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Nutriband Inc. NTRB | Leave a comment

Vivakor Inc. (NASDAQ: VIVK) Pioneers Sustainable Oilfield Waste Management

Posted on June 20, 2025 by MissionIR
  • Oil refineries have a significant environmental impact due to the emission of atmospheric pollutants, the production of toxic waste and the intensive consumption of water and energy.
  • Companies such as Vivakor play a crucial role in bridging environmental needs and industrial evolution.
  • From an investor perspective, Vivakor offers both an environmental impact and growth potential.

In an era where environmental responsibility intersects with energy production, Vivakor (NASDAQ: VIVK) stands out as a vertically integrated energy infrastructure and environmental services company focused on the transportation, storage, reuse and remediation of oilfield fluids and waste. The company’s comprehensive approach ensures that oil extraction isn’t merely productive, it’s responsible.

The oil and gas industry has historically contributed significantly to greenhouse-gas emissions and environmental contamination. “Oil refineries are industrial facilities that have a significant environmental impact due to the emission of atmospheric pollutants, the production of toxic waste and the intensive consumption of water and energy,” reports Kunak (ibn.fm/BuHiF). “These complexes release harmful gases that affect air quality, leading to the degradation of ecosystems and climate changes. Additionally, soil and nearby water sources contamination due to spills and industrial discharges is another looming risk, threatening biodiversity and human health. Therefore, controlling industrial emissions is key to minimizing these negative effects.

“Oil extraction is a complex process that involves several operations based on advanced technologies,” the report continued. “This process generates greenhouse-gas emissions such as carbon dioxide (“CO2”) and methane (“CH4”). Refineries are the third-largest global emitter of GHGs. The oil industry’s primary environmental harm lies in gaseous emission, as it is responsible for 6% of global industrial net emissions.”

With the global produced water treatment market projected to reach $12.2 billion by 2028, up from $8.6 billion in 2023 (ibn.fm/8k5ER), companies such as Vivakor play a crucial role in bridging environmental need and industrial evolution. Vivakor’s business model meets today’s demand for sustainability on multiple fronts. By integrating logistics and remediation, it delivers end-to-end solutions that align with tightening regulations and growing expectations for corporate environmental accountability (ibn.fm/J4kAs). Instead of treating waste as a byproduct, Vivakor transforms it into an asset, reprocessing fluids and soil to extract value and reduce ecological harm. This approach reduces liability, lowers environmental risk and creates new revenue streams.

In the fourth quarter of 2024, Vivakor’s revenue surged 201% year-over-year to $41.7 million, propelling its annual run rate near $160 million (ibn.fm/VVwne). This dramatic growth came on the heels of completing additional gathering lines for its Omega Pipeline System in Oklahoma and acquiring Endeavor Entities, moves that solidified its position in logistics and environmental services. With more than 300,000 barrels per month moving through its gathering assets, a trucking fleet exceeding 165 crude oil and 105 water-hauling units, and the only Kuwait Oil Company-approved recycling processing center capable of reducing oil concentration in soil to below 0.5%, Vivakor is setting new operational standards.

From an investor perspective, Vivakor offers both an environmental impact and growth potential. The global oilfield services market was valued at $268.1 billion in 2022 and is projected to grow to $346.45 billion by 2032 at a CAGR of 2.6%, while water treatment — a vital and expanding segment — represents an immediate multibillion dollar opportunity. Vivakor’s vertical integration, long-term contracts and expanding asset base provide recurring revenues and downside protection.

“Investing in clean technologies not only benefits the environment but also enhances operational efficiency and cost effectiveness,” says management, reflecting the company’s dual mandate. Thanks to a series of strategic acquisitions, including Silver Fuels Delhi and White Claw Colorado in 2023, Vivakor has bolstered its midstream footprint across prime U.S. energy basins. 

Vivakor CEO James Ballengee describes 2024 as “transformative,” highlighting integration of logistics, gathering, storage, and sustainable services into a single infrastructure platform. “Thanks to the support of our shareholders, lenders, business partners, operating and management teams and board of directors, Vivakor had a highly successful 2024, expanding our business organically and through acquisitions,” he said. “The Vivakor team has been, and continues to, work tirelessly to fully integrate and improve efficiencies from the business combination with those entities, and I couldn’t be more pleased with the results.”

For investors seeking exposure to energy with an environmental twist, Vivakor offers a compelling blend. Its financial performance — marked by triple-digit revenue growth — and its strategic positioning in an environmentally conscious sector are rare among oilfield services providers. As sustainability becomes a focus for regulators, consumers and corporate buyers, vertically integrated companies that marry environmental remediation with logistics will be increasingly attractive to capital markets.

Vivakor’s commitment to sustainable growth, combined with its clear-cut operational metrics and market opportunity, suggests it is one of those rare opportunities that are both mission driven and market smart. Investors aligned with Environmental, Social, and Governance (“ESG”) principles and seeking growth in the energy transition space may find Vivakor a rare bridge between tradition and transformation. 

For more information, visit the company’s website at https://vivakor.com.

NOTE TO INVESTORS: The latest news and updates relating to VIVK are available in the company’s newsroom at https://ibn.fm/VIVK

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Vivakor Inc. VIVK | Leave a comment

MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Signs MOU to Advance Quantum Computing in South Korea

Posted on June 18, 2025 by MissionIR

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, announced that it has signed a memorandum of understanding (MOU) with Yonsei University and Incheon Metropolitan City aimed at accelerating quantum computing adoption in South Korea. Supporting the region’s ambition to become a global quantum technology hub, the MOU outlines plans to work together on research, talent development, and use case exploration across biotechnology, materials science and other sectors. The MOU also facilitates the organizations’ collaborative efforts towards the acquisition of a D-Wave Advantage2™ quantum system at the Yonsei University International Campus in Songdo, Yeonsu-gu,  Incheon.

To view the full press release, visit https://ibn.fm/A1l5p

About D-Wave Quantum Inc.

D-Wave is a leader in the development and delivery of quantum computing systems, software, and services. We are the world’s first commercial supplier of quantum computers, and the only company building both annealing and gate-model quantum computers. Our mission is to help customers realize the value of quantum, today. Our quantum computers, the world’s largest, are available on-premises or via the cloud, supported by 99.9% availability and uptime. More than 100 organizations trust D-Wave with their toughest computational challenges. With over 200 million problems submitted to our quantum systems to date, our customers apply our technology to address use cases spanning optimization, artificial intelligence, research and more. Learn more about realizing the value of quantum computing today and how we’re shaping the quantum-driven industrial and societal advancements of tomorrow: www.dwavequantum.com.

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

Forward Looking Statements

Certain statements in this press release are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including the risks set forth under the heading “Risk Factors” discussed under the caption “Item 1A. Risk Factors” in Part I of our most recent Annual Report on Form 10-K or any updates discussed under the caption “Item 1A. Risk Factors” in Part II of our Quarterly Reports on Form 10-Q and in our other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this press release in making an investment decision, which are based on information available to us on the date hereof. We undertake no duty to update this information unless required by law.

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Among Early Adopters of Bitcoin Treasury Strategies Amid Growing Trend

Posted on June 18, 2025 by MissionIR
  • SolarBank Corporation joins a group of 61 public companies adopting bitcoin treasury strategies.
  • The company expects to bridge growing investor interest in crypto with the stability of renewable energy.
  • SolarBank has applied to open an account with Coinbase Prime for custody and related services.
  • CEO Richard Lu says the strategy helps attract a new class of tech-savvy investors.

Disseminated on behalf of SolarBank Corporation

SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., announced this month it will begin holding bitcoin as part of its treasury reserves. The strategy marks SolarBank as one of the early adopters of what is becoming an increasingly common approach among publicly traded firms looking to diversify assets and attract new investors.

The concept of a bitcoin treasury strategy involves companies allocating a portion of their cash or reserves into the cryptocurrency. While it remains a relatively niche approach, a report by Reuters notes that 61 publicly listed companies not primarily focused on digital assets have now adopted such strategies (https://ibn.fm/erCis).

Many of these firms were influenced by the gains of Strategy (formerly MicroStrategy), which began accumulating bitcoin in 2020 and now holds more than $63 billion of the asset.

According to Standard Chartered, the number of companies adopting this strategy have doubled their bitcoin holdings over the past two months, now holding just under 100,000 coins collectively. Firms like Trump Media & Technology Group, which raised $2.5 billion recently, are part of this trend. A separate joint venture involving SoftBank, Tether, and Cantor Fitzgerald is also seeking to acquire bitcoin on a large scale.

SolarBank has disclosed that it intends to use the net cashflow from its Geddes Project to purchase bitcoin. The Geddes Project is expected to be operational by the end of June 2025. The company has not yet purchased any bitcoin. However, CEO Richard Lu framed the decision as a strategic blend of traditional energy business with contemporary digital asset exposure.

“Traditionally, people invest in utilities as [an] afterthought. It’s a very low return. It’s a stable return,” Lu told Reuters. “So, how do we bridge the excitement of the new world and a classic industry? We feel that the crypto part of that is a bridge we need to cross.”

SolarBank says the decision is designed to align the company with emerging digital asset infrastructure while differentiating its utility-focused profile from competitors. The company has filed to open an account with Coinbase Prime (NASDAQ: COIN) to securely custody bitcoin and manage its digital assets.

The company cited several intended benefits for the strategy. These include financial resilience against inflation, potential access to institutional capital, and the ability to offset bitcoin-related energy use with its clean energy generation portfolio.

By integrating bitcoin into its treasury, SolarBank is also targeting a new base of investors interested in blockchain, digital finance, and decentralized technologies. The company emphasized that its clean energy operations may offer a unique positioning in the current crypto landscape, where environmental concerns around mining remain prominent.

For more information, visit the company’s website at SolarBankCorp.com.

There are several risks associated with the development of the projects detailed in this report. The development of any project is subject to the continued availability of third-party financing arrangements for the project owners and the risks associated with the construction of a solar power project. There is no certainty the projects disclosed in this report will be completed on schedule or that they will operate in accordance with their design capacity.

This report contains forward looking information. Please refer to the press release entitled “Bitcoin Purchases to be made by SolarBank Using Net Cash from Geddes Solar Power Project” for additional details on the statements, risks and assumptions.

NOTE TO INVESTORS: The latest news and updates relating to SUUN are available in the company’s newsroom at https://ibn.fm/SUUN

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in SolarBank Corp. SUUN | Leave a comment

MissionIRNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) to Deploy Fingerprint Drug Testing System Across MWS Sites in Australia

Posted on June 18, 2025 by MissionIR

Intelligent Bio Solutions (NASDAQ: INBS) announced that Managed Waste Service (MWS), a leading Australian waste management provider, will implement INBS’ Intelligent Fingerprinting Drug Screening System across its New South Wales operations. Covering over 20 remote land clearing and green waste sites, this marks MWS’s first shift to in-house, on-site drug testing for pre-employment, random, and for-cause purposes. The fingerprint-based system delivers non-invasive results in under ten minutes, enabling rapid safety decisions without disrupting field operations. INBS continues to expand its reach into safety-critical industries, with its scalable, sweat-based drug testing now in use by over 450 organizations across 24 countries.

To view the full article, visit https://ibn.fm/k4tsl

About Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The Company’s current customer segments outside the US include construction, manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners.

NOTE TO INVESTORS: The latest news and updates relating to INBS are available in the company’s newsroom at https://ibn.fm/INBS

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Intelligent Bio Solutions Inc. INBS | Leave a comment

Soligenix Inc. (NASDAQ: SNGX) Proprietary Therapy Shows Promise in Treatment of Psoriasis

Posted on June 18, 2025 by MissionIR
  • Psoriasis affects approximately 3% of the adult population in the United States, translating to more than 7.5 million individuals.
  • By using visible light, Soligenix’s SGX302 aims to mitigate risks while effectively reducing inflammation and promoting skin healing.
  • A phase 2a study demonstrated that SGX302 was well tolerated, with no significant adverse events reported.

Psoriasis is more than just a skin condition — it’s a lifelong autoimmune disorder that disrupts daily life with painful, inflamed patches and an emotional toll that can be just as severe as the physical symptoms. Soligenix (NASDAQ: SNGX) is at the forefront of developing innovative therapies for this condition, notably SGX302 (synthetic hypericin), a novel treatment currently undergoing Phase 2a clinical trials aimed at addressing mild to moderate psoriasis.

Psoriasis affects approximately 3% of the adult population aged 20 years or older in the United States, translating to more than 7.5 million individuals. Notably, around 600,000 adults in the United States live with undiagnosed psoriasis. The prevalence is similar between males (2.8%) and females (3.2%). Globally, the condition impacts about 125 million people, or 2–3% of the world’s population (https://ibn.fm/GAK4y).

Psoriasis is not merely a skin disorder; it is associated with several comorbidities, including psoriatic arthritis, cardiovascular disease and depression. Approximately 30% of individuals with psoriasis develop psoriatic arthritis, a condition that causes joint pain and stiffness. The economic burden of psoriasis in the United States is substantial, with direct and indirect costs estimated to be between $112 billion and $135 billion annually (https://ibn.fm/UKxIo).

Current treatment options for psoriasis include topical therapies, phototherapy, and systemic medications such as biologics. While these treatments can be effective, they often come with limitations, including side effects, high costs, and the need for long-term administration. Many patients with mild to moderate psoriasis are seeking alternatives that are both effective and have a favorable safety profile.

Soligenix’s SGX302 represents a promising advancement in this context (https://ibn.fm/emX4P). Utilizing synthetic hypericin, SGX302, or HyBryte(TM), is a novel, first-in-class, photodynamic therapy using safe, visible light that targets and treats psoriatic lesions. This approach is distinct from traditional phototherapy, which often relies on ultraviolet (“UV”) light, potentially leading to long-term skin damage. By using visible light, SGX302 aims to mitigate these risks while effectively reducing inflammation and promoting skin healing.

Soligenix has released top-line interim results from its phase 2a clinical trial evaluating SGX302 in patients with mild to moderate psoriasis (https://ibn.fm/ZQTzZ). The study demonstrated that SGX302 was well tolerated, with no significant adverse events reported. In interim results, 50% of patients receiving SGX302 were considered “Almost Clear” in the Psoriasis Area and Severity Index (“PASI”) scores compared to baseline, indicating a reduction in both the extent and severity of psoriatic lesions. These findings suggest that SGX302 has the potential to offer a safe and effective treatment option for individuals with mild to moderate psoriasis.

Soligenix continues to build on its broader mission of delivering therapeutic solutions for difficult-to-treat conditions, with SGX302 marking a noteworthy advancement in its pipeline. By focusing on non-immunosuppressive strategies for managing psoriasis, the company is working to fill a critical gap for patients seeking alternatives to current therapies, many of which come with significant long-term risks or limited efficacy.

As the phase 2a trial moves forward, SGX302’s progress remains closely watched by researchers and clinicians alike. Its novel mechanism and promising early results signal a potential shift in how mild to moderate psoriasis is treated, highlighting Soligenix’s role in reshaping the future of dermatologic care through innovation and precision-targeted drug development.

For more information, visit www.Soligenix.com.

NOTE TO INVESTORS: The latest news and updates relating to SNGX are available in the company’s newsroom at https://ibn.fm/SNGX

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Soligenix Inc. SNGX | Leave a comment

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Advances Waterberg Project  Amid Third Straight Year of Platinum Deficits

Posted on June 18, 2025 by MissionIR
  • The platinum market recorded a deficit of approximately 992,000 ounces in 2024 and is forecast to remain in substantial undersupply through 2025.
  • This tightening supply-demand balance has prompted a sharp rally in platinum prices.
  • Platinum Group Metals Ltd. is working to address a portion of the world’s platinum need.

The platinum market is entering its third straight year of major structural supply deficits—a situation that is adding both pressure and opportunity for players such as Platinum Group Metals (NYSE American: PLG) (TSX: PTM), a development-stage mining company focused on its flagship Waterberg project in South Africa to help unlock new platinum supply while exploring innovative industrial applications for platinum and palladium.

According to the World Platinum Investment Council, the platinum market recorded a deficit of approximately 992,000 ounces in 2024 and is forecast to remain in substantial undersupply through 2025, with deficits estimated at 966,000 ounces for this year (https://ibn.fm/VOZDI). These supply gaps are driven by sharply constrained mine output—forecast to decline by up to 6% this year—and weak recycling rates, which have failed to keep pace with demand. With inventories dwindling fast, it’s clear the market is approaching a critical tipping point.

Adding further strain, global demand remains resilient. While auto demand may soften as EV adoption accelerates, the slower-than-expected EV transition has bolstered continued platinum use in internal combustion and hybrid vehicle catalytic converters. Jewelry demand is also on the rise, especially as consumers, particularly in China, pivot to platinum as a cheaper alternative to gold.

Furthermore, a Sprott special report noted that “perhaps the most striking development is the 300% surge in investment demand highlighted by WPIC, driven by strong Chinese bar and coin demand and a doubling of speculative net long positions. Investment demand is forecast at 688,000 ounces in 2025, marking the third consecutive year of net positive investment. This shift reflects growing investor recognition of platinum’s undervaluation, especially as prices break a 15-year downtrend and speculative interest pivots from short to long positions.”

This tightening supply-demand balance has prompted a sharp rally in platinum prices. Metals analysts report platinum recently surged over 10% in June alone, reaching four-year highs above $1,200 per ounce (https://ibn.fm/BaiIj). Market commentary highlights that the persistent deficits and declining above-ground inventories are laying the groundwork for prolonged price strength.

Platinum Group Metals is working to address a portion of the world’s platinum need. The company’s Waterberg project, on the Northern Limb of South Africa’s Bushveld Complex — the planet’s prime platinum reserve — is being advanced toward development and construction (https://ibn.fm/Cwoq8). The September 2024 Waterberg DFS update (https://ibn.fm/4iMo9) shows Waterberg is being designed as a fully mechanized, underground mine targeting platinum as well as other key metals, including palladium, rhodium and gold, (“4E” or “PGM”) with copper and nickel byproducts.

The October 2024 DFS update emphasized Waterberg’s potential to become one of the lowest-cost, largest underground PGM operations globally, leveraging shallow, decline-access and mechanized mining. Through these efficiencies, the project could deliver much-needed new platinum supply at a time when market demand for the metal is strong.

“The 2024 DFS validates the world-class nature of the Waterberg Project,” said Frank R. Hallam, PLG president and CEO. “Engineering teams from Stantec, DRA and Fraser McGill have collaborated to achieve an optimized and de-risked mine plan while also minimizing capital requirements. The primary objectives of the 2024 DFS were to update and minimize capital and operating costs, and to simplify the construction, ramp up and operating profile of the Waterberg Mine. I believe these objectives have been achieved.”

“We look forward to advancing the Waterberg Project for the benefit of our partners and local communities, as well as all the people of South Africa,” Hallam continued. “The Waterberg Project is planned to create approximately 2,000 jobs during construction and approximately 1,425 mostly high-skilled jobs once steady state mining is achieved. PGMs, copper and nickel play key roles in automotive emissions control and energy transition technologies, including that found in battery electric, plug-in hybrid, gasoline hybrid and hydrogen fuel cell vehicles. The Waterberg Project is a long-life asset capable of profitably producing these critical metals.”

Platinum Group Metals is positioning itself at the confluence of a rapidly tightening platinum market and technological innovation. With global deficits reaching up to a million ounces, supply tightening through declining mined supply and weak recycling, and growing industrial, automotive, jewelry, and investment demand keeping prices buoyant, the company’s Waterberg project represents a timely source of new material. Success in bringing Waterberg into production could allow Platinum Group Metals to not only help ease market shortages but also capitalize on a rising price environment.

For more information, visit www.PlatinumGroupMetals.net.

NOTE TO INVESTORS: The latest news and updates relating to PLG are available in the company’s newsroom at https://ibn.fm/PLG

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Platinum Group Metals Ltd. PLG | Leave a comment